In a groundbreaking medical achievement Centre for Sight Hospital in Surat has successfully performed the first implantation in India of the latest Trabecular Micro bypass stunt.

Dr Amit Pandey, consultant Glaucoma at Centre for Sight Surat, is the surgeon who performed this advanced surgery. He quoted, “The Latest Trabecular Shunt is a cutting-edge device designed to effectively manage intraocular pressure and improve the quality of life for individuals affected by this sight-threatening condition. This device is implanted in the eye through incision which is less than 1 mm and takes less than 5 minutes. “

Glaucoma is one of the leading cause of irreversible blindness in our country. 

In a conventional glaucoma surgery, we create a new pathway to depressurise the eye. But this surgery requires multiple incisions, sutures and the use of anti-fibrotic medicines. So the conventional surgery is usually limited to Advanced and severe uncontrolled Glaucoma and its use in mild to moderate cases is still Limited.

Minimally Invasive or micro incision Glaucoma Surgery (MIGS) is preferably being done in early mild to moderate glaucoma, especially those patients who are on multiple medications or who are not able to tolerate or put their eye drops regularly. The latest Shunt implant improves on the previous model by enhancing the safety and delivery system.  Centre for Sight is committed to bringing the best technologies from across the world to India for the betterment of patients suffering from eye diseases

Dr. Paresh Vaidya Medical Director of Center For Sight, Surat said” As you all are aware Glaucoma is silent killer of eyesight. So early diagnosis with state of art technological instruments has opened up horizons to treat disease in early stages. MIGS (micro incision glaucoma surgery),  and now first time ever done in India the Latest Trabecular Shunt at Centre for Sight, Surat. This is a significant and remarkable milestone in field of Glaucoma surgery. This revolutionary technique will improve results, helps in early treatment and save eyesight.”